Trial Profile
Evaluation of the effect of tetravalent (A, C, Y, W-135) meningococcal conjugate vaccine [meningococcal vaccine groups A C Y W-135 conjugate] on serogroup-specific carriage of Neisseria meningitidis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Jul 2007
Price :
$35
*
At a glance
- Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary)
- Indications Meningococcal infections
- Focus Therapeutic Use
- 25 Oct 2006 New trial record.